Treatment approach in patients with hyperbilirubinemia secondary to liver metastases in gastrointestinal malignancies: a case series and review of literature

BACKGROUND: Treatment of patients with severe liver dysfunction including hyperbilirubinemia secondary to liver metastases of gastrointestinal (GI) cancer is challenging. Regimen of oxaliplatin and fluoropyrimidine (FP)/folinic acid (FA) ± a monoclonal antibody (moAb), represents a feasible option c...

ver descrição completa

Detalhes bibliográficos
Autor principal: Quidde, J (author)
Outros Autores: Azémar, M (author), Bokemeyer, C (author), Arnold, D (author), Stein, A (author)
Formato: article
Idioma:eng
Publicado em: 2016
Assuntos:
Neoplasias Gastrointestinais
Hiperbilirrubinemia
Neoplasias Hepáticas/secundária
Gastrointestinal Neoplasms
Hyperbilirubinemia
Liver Neoplasms/secondary
Texto completo:http://hdl.handle.net/10400.26/14198
País:Portugal
Oai:oai:comum.rcaap.pt:10400.26/14198

Texto Completo

http://hdl.handle.net/10400.26/14198

Registos relacionados